By Thomas Anderson, Rotem Petranker — 2018
We just ran the first ever pre-registered scientific study on the microdosing of psychedelics and found some very promising results.
Read on theconversation.com
CLEAR ALL
In the 1950s a group of pioneering psychiatrists showed that hallucinogenic drugs had therapeutic potential, but the research was halted as part of the backlash against the hippy counterculture.
LSD, or lysergic acid diethylamide, is a synthetic drug with potent psychedelic properties. Commonly known as acid, it was originally derived from compounds found in ergot, a fungus that grows on rye.
Psychedelic drugs are making a quiet comeback, as a smattering of recent studies have demonstrated their medicinal potential. The latest finding suggests it is time to revisit LSD as a treatment for addiction.
The drug lowers brain barriers, allowing distant regions to talk and thoughts to flow more freely.
A well-kept American secret is that the CIA-funded research that exploited incarcerated Black Americans along with other vulnerable groups in America’s hunt for a “mind-control” drug.
You’ve probably heard about microdosing, the “productivity hack” popular among Silicon Valley engineers and business leaders. Microdosers take regular small doses of LSD or magic mushrooms.
1
A Really Good Day is Waldman’s first-person account of her month-long adventure microdosing LSD.
A new review of studies finds that LSD, psilocybin, and MDMA hold potential for treating mental illness.
The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.
The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.
2